CLLS vs AVIR
Comparison between Cellectis (CLLS, Company) and Atea Pharmaceuticals Inc (AVIR, Company).
Both CLLS and AVIR are from the Healthcare sector.
5-Year PerformanceCLLS has outperformed AVIR, delivering a return of -26.8% compared to -27.7%
CLLS vs AVIR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CLLS vs AVIR - Historical Returns
Returns include dividend reinvestment.
CLLS vs AVIR - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | CLLS | AVIR |
|---|---|---|
| 2026 | -36.25% | +22.13% |
| 2025 | +167.40% | +4.39% |
| 2024 | -41.37% | +4.36% |
| 2023 | +35.68% | -36.59% |
| 2022 | -76.05% | -47.66% |
| 2021 | -70.58% | -78.42% |
| 2020 | +51.94% | +37.71% |
| 2019 | -0.29% | N/A |
| 2018 | -44.67% | N/A |
| 2017 | +60.87% | N/A |
| 2016 | -43.80% | N/A |
| 2015 | -21.04% | N/A |
CLLS vs AVIR Drawdown Comparison
The maximum drawdown for CLLS was -97.96%, occurring on Oct 31, 2023. This drawdown has not yet recovered.
The maximum drawdown for AVIR was -97.12%, occurring on May 14, 2025. This drawdown has not yet recovered.
The current CLLS drawdown is -93.58%. The current AVIR drawdown is -95.19%.
| Rank | CLLS | AVIR |
|---|---|---|
| #1 | -97.96% May 28, 2015 - Oct 31, 2023 | -97.12% Feb 8, 2021 - May 14, 2025 |
| #2 | -22.01% Mar 25, 2015 - May 27, 2015 | -22.86% Nov 6, 2020 - Nov 27, 2020 |
| #3 | N/A | -19.37% Nov 27, 2020 - Dec 21, 2020 |
| #4 | N/A | -7.22% Oct 30, 2020 - Nov 4, 2020 |
| #5 | N/A | -7.15% Feb 3, 2021 - Feb 8, 2021 |
| #6 | N/A | -6.40% Jan 20, 2021 - Jan 27, 2021 |
| #7 | N/A | -5.89% Jan 8, 2021 - Jan 13, 2021 |
| #8 | N/A | -4.78% Dec 22, 2020 - Dec 28, 2020 |
| #9 | N/A | -0.86% Dec 31, 2020 - Jan 5, 2021 |
Correlation
Correlation between CLLS and AVIR is 0.90 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks